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SINTESIS, PENCIRIAN DAN AKTIVITI BIOLOGI TERBITAN BARU 
KUMARIN HIDRAZINIL THIAZOLIL  
 
ABSTRAK 
 
 
Kumarin dan thiazol merupakan dua jenis farmakofor yang penting, yang mana 
sintesisnya diberikan keutamaan dalam pelbagai bidang kimia perubatan disebabkan 
kepelbagaian aktiviti farmakologi yang berkaitan dengan komponen gelang heterosiklik. 
Kajian ini bertujuan untuk mensintesis komponen (45) yang aktif daripada segi biologi, 
dengan menggabungkan gelang thiazol dan nukleus kumarin. Dua siri baru terbitan 
hidrazinil thiazolil kumarin telah di sintesis dengan empat langkah. Langkah pertama  
ialah penyediaan sebatian asetil kumarin kondensasi Knoevenagel yang melibatkan 
penukargantian salisaldehid dengan etil asetoasetat dengan kehadiran piperidina sebagai 
mangkin. Dalam langkah kedua, pembrominan asetil kumarin dengan kehadiran 
bromin, dilakukan untuk mendapatkan bromoasetil kumarin. Thiosemikarbazon 
dihasilkan dalam langkah ketiga yang mana thiosemikarbazid dioleh dengan pelbagai 
aldehid dan keton tertukarganti dengan menggunakan asid asetik glasial sebagai 
mangkin. Langkah sintesis terakhir melibatkan sintesis dua siri baru hydrazinil thiazolil 
kumarin menenisi pensiklikan Hantzch. Salah satu siri sebatian diperoleh daripada 
tindak balas antara 3-bromoasetil kumarin dengan thiosemikarbazon yang mempakan 
terbitan aldehid, tertukanganti manakala siri yang lain didapati daripada tindak balas 
antara terbitan ketone tertukanganti thiosemikarbazon dengan 3-bromoasetil kumarin. 
Ke semua sebatian dicirikan dengan menggunkan IR, 
1
H NMR, 
13
C NMR, elemental 
 xxiii 
analisis dan spektroskopi jisim. Struktur beberapa sebatian telah dikenalpasti dengan 
kristalografi sinar X dan 2D NMR (COSY, HMQC, HMBC).   
Semua sebatian telah disaring secara in vitro bagi mengesan  aktiviti antimikrobial 
terhadap spesis bakteria Gram-positif dan Gram-negatif termasuk Mycobacterium 
tuberculosis dan Candida albicans. Aktiviti antimikrobial yang ketara telah ditunjukkan 
terhadap Mycobacterium tuberculosis oleh sebatian 70i dengan nilai MIC yang terendah 
iatu 2.6 µM. Di samping itu, sebatian 70e, 71b, 71e, 74a, 74b dan 75b menunjukkan 
aktiviti antimikrobial yang amat baik terhadap kebanyakan mikrob yang diuji.   
Semua terbitan kumarin dikaji selanjutnya untuk mengetahui aktiviti antioksidan 
dengan menggunakan ujian radikal DPPH. Keputusan kajian menunjukkan bahawa ke 
semua sebatian yang disintesis (70a–76b) mempunyi aktiviti antioksidan yang tinggi, 
manakala sebahagian sebatian terbitan (70a–70i, 73b, 74b dan 75b–75f) pula 
menunjukkan penyingkiran aktiviti yang lebih tinggi berbanding BHT (antioksidan 
sintetik) tetapi setanding dengan quercetin (antioksidan semulajadi) yang kedua-duanya 
mempakan rujukan piawai.  
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SYNTHESES, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES OF 
NEW HYDRAZINYL THIAZOLYL COUMARIN DERIVATIVES 
 
ABSTRACT 
 
Coumarin and thiazole are two important pharmacophores, the syntheses of which 
acquire great importance in medicinal chemistry due to the diverse pharmacological 
activities. The present study aims to synthesize some (45) new biologically active 
compounds by incorporating thiazole ring with coumarin nucleus. Two new series of 
hydrazinyl thiazolyl coumarin derivatives have been synthesized in four steps. The first 
step of the synthesis was the preparation of acetyl coumarins by Knoevenagel’s 
condensation of substituted salicyaldehydes with ethyl acetoacetate in the presence of 
catalytic amount of piperidine. In the second step, bromination of acetyl coumarins was 
carried out with bromine in order to yield the corresponding bromoacetyl coumarins. 
Thiosemicarbazones were synthesized in the third step by treating thiosemicarbazide 
with various substituted aldehydes and ketones in the presence of a catalytic amount of 
glacial acetic acid. The final step of the synthesis involved the preparation of two new 
series of hydrazinyl thiazolyl coumarins using Hantzsch cyclization protocol. One series 
of compounds was obtained by reacting 3-bromoacetyl coumarins with 
thiosemicarbazones derived from various substituted aldehydes, while the other series 
was furnished by treating thiosemicarbazones of substituted ketones with 3-
bromoacetylcoumarins.  All the synthesized compounds were fully characterized by IR, 
1
H and 
13
C NMR, elemental analysis and mass spectroscopy. The structures of some 
 xxv 
compounds were further confirmed by X-ray crystallography as well as 2D NMR 
(COSY, HMQC, HMBC) spectroscopic techniques.  
All of these derivatives were screened in vitro for their antimicrobial activities against 
various Gram-positive and Gram-negative bacteria species including Mycobacterium 
tuberculosis and Candida albicans. Significant activity against Mycobacterium 
tuberculosis was shown by compound 70i with the lowest MIC value of 2.6 µM. 
Moreover, compounds 70e, 71b, 71e, 74a, 74b and 75b exhibited very good 
antimicrobial activities against almost all of the tested microbial strains.  
 All synthesized hydrazinyl thiazolyl coumarin derivatives were further evaluated for 
their antioxidant activity by using DPPH˙ radical assay. The results indicated that all the 
synthesized compounds (70a–76b) exhibited very good antioxidant activity, while some 
of the derivatives (70a–70i, 73b, 74b and 75b–75f) showing radical scavenging activity 
even better than that of BHT (a synthetic antioxidant) but comparable to that of 
quercetin and catechin (natural antioxidants), the reference standards.  
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CHAPTER 1 
INTRODUCTION 
 
1.1. Coumarins 
Coumarins constitute an important class of heterocyclic compounds found throughout 
the plant kingdom. The pharmacological and biochemical activities of coumarin 
derivatives encompass an important position in heterocyclic chemistry and in medicinal 
chemistry. The term coumarin was originated from ‘coumarou’, the French vernacular 
name for Tonka beans (Dipteryx odorata), from which the coumarin was first isolated 
by Vogel in 1820 (Bruneton, 1999). Coumarin belongs to the benzopyrone class of the 
compounds and its parent molecule (1,2-benzopyrone) is composed of the fused 
benzene and α-pyrone rings (1).     
 
The coumarin derivatives are usually found as secondary metabolites in seeds, roots and 
leaves of higher plants but are found rarely in fungi and bacteria (Murray et al., 1982). 
They play a vital role in plant biochemistry and physiology by acting as antioxidants, 
enzyme inhibitors and precursors of toxic substances. Moreover, coumarins are also 
involved in the control of respiration, photosynthesis and in the defence mechanism of 
plants against infections. Coumarins can be classified on the basis of various types of 
substitutions in the benzene or pyrone rings that influence their therapeutic values 
(Keating et al., 1997). There are four main coumarin sub-groups: 
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i. Simple coumarins are hydroxylated, alkoxylated and alkylated derivatives of the 
parent molecule, such as 7-hydroxycoumarin (2). 
ii. Furanocoumarins are based on five-membered furan ring attached to the 
coumarin nucleus either linearly or angularly. Psoralen (3) and angelicin (4) are 
good examples of furanocoumarins. 
iii.  Pyranocoumarins are similar to furanocoumarins but contain six-membered 
pyran ring, for example seselin (5) and xanthyletin (6). 
iv. Pyrone-substituted coumarins have substitution on pyrone ring, usually at C-3 or 
C-4 position. The synthetic compound warfarin (7) belongs to this type of 
coumarin. 
 
 
Diverse biological activities associated with the coumarin nucleus have drawn a 
considerable attention of synthetic chemists in recent years. The synthesis of coumarin 
derivatives can be carried out by various synthetic procedures, which include Pechmann 
reaction, Perkin reaction, Reformatsky reaction and Knoevenagel reaction. Koevenagel 
reaction was used to synthesize the novel coumarin derivatives in this study. It is a 
simple, fast and general procedure to synthesize 3-acetylcoumarins, where the 
condensation of salicylaldehyde or its derivative with ethyl acetoacetate leads to 
  
 3 
coumarin synthesis in the presence of piperidine as a catalyst. The reaction proceeds 
without any solvent. The solvent-free conditions have many advantages as solvents are 
often expensive, toxic, difficulty to remove solvents with high boiling points, and are 
environment polluting agents. Moreover, the work-up and purification procedures are 
simplified by avoiding liquid-liquid extraction for the isolation of reaction products 
(Bogda 1998). 
 
1.2. Biological activities of coumarins 
The natural and synthetic coumarin derivatives possess remarkable activities against 
bacteria, fungi, viruses and tumours. They also act as anti-coagulants, free radical 
scavengers, analgesics and anti-inflammatory agents. The physiological, bacteriostatic 
and anti-tumour activities of coumarins encourage the derivatization and screening of 
their analogues as new therapeutic agents. 
 
1.2.1. Antimicrobial activities of coumarins 
Coumarin derivatives with diverse structures are reported to have remarkable activities 
against different strains of bacteria, fungi and viruses. Antibiotics of coumarin group 
such as novobiocin (8), clorobiocin (9) and coumermycin A1 (10) are potent inhibitors 
of DNA gyrase (Hooper et al., 1982). All these antibiotics have been isolated from 
different species of Streptomyces and contain 3-amino-4-hydroxycoumarin moiety and 
a substituted deoxysugar as the important parts of their structures, which are responsible 
for their biological activities (Chen and Walsh, 2001). 
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    Besides naturally occurring coumarin antibiotics, several attempts were made to 
synthesize the coumarin-based antimicrobial compounds. Ronad and co-workers (2010) 
synthesized a series of 7-(2-substitutedphenylthiazolidinyl)-benzopyran-2-one 
derivatives (11) and evaluated the synthesized compounds against various bacterial and 
fungal strains. The results indicated that para-substituted nitro, methoxy and fluoro 
derivatives exhibited very good antibacterial and antifungal activities at a concentration 
of 100 µg/mL. 
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A subsequent study (Ajani and Nwinyi, 2010) reported the synthesis and antimicrobial 
activity of 3-acetylcoumarin derivatives, derived from its condensation with aromatic 
and heteroaromatic aldehydes to afford the corresponding aromatic chalcones (12) and 
heteroaromatic chalcones (13, 14) respectively. The antibacterial activity of these 
compounds was tested by using three Gram-positive and two Gram-negative strains of 
bacteria. The MIC values of all the synthesized compounds were reported within the 
range of 7.8-31.2 µg/mL. 
Moreover, Emami et al. (2008) reported a new series of quinolone-based coumarin 
derivatives with noteworthy antibacterial activities against various strains of 
Staphylococcus and Bacillus. The results indicated that N-[2-(coumarin-3-yl)ethyl] 
piperazinyl quinolone derivatives (15) exhibited equivalent or more potent antibacterial 
activities against all the tested strains as compared to that of the parent quinolones 
(norfloxacin, ciprofloxacin and enoxacin). 
 
 
Another library of pyrimidino (16), pyridino (17) and pyrrolo (18) benzopyran 
derivatives containing heterocyclic rings fused with a coumarin moiety was synthesized 
by a group of researchers (Al-Haiza et al., 2003) and they found that some of the 
synthesized compounds showed antibacterial activities against Gram-negative bacteria 
comparable to that of amoxicillin, the reference standard. Moreover, some of these 
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derivatives showed excellent activity against Aspergillus niger, which appeared to be 
even higher than the reference drug, mycostatin. 
 
One of the most pathogenic bacterial strains is the Mycobacterium tuberculosis, which 
is responsible for most of the tuberculosis cases. Almost one-third of the world’s 
population is infected by this pathogen and 1.7 millions deaths were attributed to this 
microorganism in 2009. This problem has now become more severe due to the 
resistance developed by Mycobacterium tuberculosis against the first line as well as 
second line drugs. Multidrug-resistant TB cases reported in 2010 were to be their 
highest level (Koul et al., 2011). Hence, there is a need to develop new molecules 
against this deadly pathogen. Compounds having benzopyran core with several 
substitution patterns comprise a group exhibited remarkable activity against 
Mycobacterium (Ananthan et al., 2009). One of the series of this group of compounds 
has variously substituted acetic acid ester moieties attached through an oxygen atom to 
C-7 position of the coumarin core (19). This series consisted of 87 compounds, 31% (27 
compounds) of which showed inhibition more than 90% in the initial screening. The 
most potent compounds with TB IC90 values of 0.2-2.0 µg/mL were found to be those 
with substitution at C-4 along with the acetic acid moiety at C-7 position of the 
coumarin ring. The other analogous series of this group has a distinctive substitution 
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pattern, in which only one position of the coumarin ring was substituted with a 
carboxamide group at C-3 (20). This series consisted of 25 compounds and seven of 
which demonstrated more than 90% inhibition of M. tuberculosis in the primary assay. 
 
 
Coumarin derivatives are also potential antiviral drugs. Some new 
benzimidazole-coumarin conjugates were studied as anti-hepatitis C virus agents (Hwu 
et al., 2008). The two moieties were linked by methylenethio linkage. Among the 
nineteen new conjugated compounds, 2-[(6ˊ-bromocoumarin-3ˊ-yl)methylenethio]-5-
fluorobenzimidazole (21) and its derivative  -[(   ,3  ,   ,6  -tetra-O-acetyl glucopyranose-
  -yl]-2-[(6ˊ-bromocoumarin-3ˊ-yl)methylenethio] (22) showed EC50 values of 3.4 and 
4.1 µM respectively against the hepatitis C virus. 
 
 Moreover, Dharmesh et al. (2009) reported three novel series of 2-(coumarin-4-yloxy)-
4,6-(disubstituted)-s-triazine derivatives as novel non-nucleoside reverse transcriptase 
inhibitors (NNRTIs) and their activities were assessed against human 
immunodeficiency virus HIV-1 (III-B), HIV-2 (ROD) and the double RT mutant HIV-1 
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(K103N and Y181C). The study established that substitutions at positions 4 and 6 of the 
coumarinyl-triazine scaffold showed moderate to good anti-HIV activity against tested 
HIV-strains compared to those of nevirapine and efavirenz, the reference standards. 
Compound 23 exhibited the highest activity with IC50 value of 1.07 µg/mL against 
HIV-1. In addition, the IC50 values of other para-substituted derivatives were within the 
range of 6.86-67.70 µg/mL (Mahajan et al., 2009). 
 
 
1.2.2. Antioxidant activity of coumarins 
Antioxidants can be defined as substances, which in relatively low concentrations as 
compared to the oxidizable substrates significantly delay or prevent the oxidation 
process (Halliwell, 1994). The continuous metabolic reactions in a living system 
produced reactive oxygen species, such as hydroxyl (HO˙ , peroxyl (ROO˙  and 
superoxide (O2˙ ˙ radicals. These free radicals are highly reactive and react readily with  
biomolecules and readily induce the chain reaction of free radicals formation (Halliwell 
and Gutteridge, 1990). The free radical induced oxidation of biomolecules is the major 
cause of various diseases including atherosclerosis, cancer, inflammation and arthritis 
(Aruoma, 1998). There is always a need to explore new antioxidants that can stop the 
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oxidative damages caused by the free radicals chain reaction by neutralizing them into 
the diamagnetic molecules. 
Various coumarin derivatives are reported to exhibit the tissue-protective antioxidant 
property by acting as scavengers of free radicals. The antioxidant property of coumarins 
can be attributed to their structural similarities with flavonoids and benzophenones 
(Beillerot et al., 2008). Most of the hydroxy coumarins are potent H˙ donors and after 
donation they exist in the radical form. The radical forms of these derivatives are 
stabilized by electron delocalization across the highly conjugated molecular skeleton 
and thus prevented it to take part in oxidative reactions (Sharma et al., 2005). 
In vitro studies of some natural and synthetic coumarin dihydroxy derivatives revealed 
that ortho-dihydroxy coumarins were more effective than meta-substituted derivatives 
as lipid peroxidation inhibitors (Paya et al., 1992). A subsequent study was conducted 
on the structure-activity relationship of some dihydroxy-4-methyl coumarins (DHMC) 
and their ternary (1:1:1) complexes with Fe (III) and ADP. The antioxidant capacity of 
all the synthesized compounds was determined by their superoxide radical (O2˙)˙ 
scavenging activities. the The highest radical scavenging activity was shown by 
7,8-dihydroxy,4-methyl derivative (24) and its complex with Fe (III)-ADP having IC50 
values of 34 and 10.5 µM respectively. The results of structure-activity relationship 
suggested that the introduction of hydroxyl groups at C-7 and C-8 position of coumarin 
increases the antioxidant ability considerably (Sharma et al., 2005). 
Vukovic et al. (2010) reported a series of imino and amino derivatives of 
4-hydroxycoumarins with antioxidant activity. This study revealed that amino 
derivatives exhibited higher scavenging activity as compared to that of the imino 
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analogues. The para-nitro phenyl derivatives of amino series (25) exhibited the most 
potent activity with IC50 value of 25.9 µM that was comparable to that of BHT, the 
reference standard. The results could be attributed to the presence of the amino group, 
which enhances the activity along with the hydroxyl group. Moreover, the 
intra-molecular hydrogen bonding in these molecules contributes additionally to 
increase the acidity of protons which in turn can be donated easily to the DPPH radical.  
 
A related study (Chen et al., 2006) was also conducted on the antioxidant potential of 
ortho-hydroxy amino derivatives of coumarins. This study demonstrated that coumarin 
derivatives with ortho-hydroxy-amino group exhibited even more potent antioxidant 
activities than that of the monohydroxy or dihydroxy derivatives of coumarins. This 
study suggested that ortho-hydroxy-amino group can be used as a potential functional 
group to synthesize novel antioxidants. The results of this study were further supported 
by the findings of Tyagi et al. (2005), who synthesized six novel 4-methylcoumarins 
with different functional groups, such as amino, hydroxyl, N-acetyl, acetoxy and nitro 
and examined their in vitro effects on NADPH dependant liver microsomal lipid 
peroxidation. They concluded that the amino group can be an effective substitute for 
hydroxyl group as it caused a dramatic inhibition of lipid peroxidation.  
Besides these, antioxidant properties of furanocoumarins (26) (Piao et al., 2004), bis 
and tetrakis-4-hydroxycoumarins (27, 28) are also documented (Hamdi et al., 2008). 
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1.2.3. Anti-cancer activity of coumarins 
Anti-cancer drugs are usually designed to damage the abnormally dividing cells by 
interrupting the process of cell division. Such drugs include DNA intercalating agents, 
DNA cross-linking agents, cytoskeleton-disrupting agents and anti-metabolites. 
Though, these drugs are effective, they exhibit severe side effects on normal 
proliferating tissues. However, literature reported several studies on the 
anti-proliferative and anti-tumour activities of various coumarin and its derivatives, 
which are not only beneficial for the treatment of cancer, but also used to treat the side 
effects of radiotherapy and chemotherapy (Grotz et al., 2001). 7-Hydroxycoumarin, for 
example was reported to be a highly effective compound which inhibited the prostate 
cancer, malignant melanoma and metastatic renal cell carcinoma in clinical trials 
(Thornes et al., 1994, Marshall et al., 1991). The in vitro structure-activity relationship 
studies of coumarin derivatives can be related to the presence and the positions of 
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hydroxyl groups in their structures. It was found that cytotoxic activity was enhanced in 
the derivatives containing ortho-dihydroxy substituents (Kolodziej et al., 1997).  
Reddy et al. (2004) reported the syntheses of coumarin-3-(N-aryl)sulphonamides (29) 
via Knoevenagel condensation reaction of anilinosulfonylacetic acids with substituted 
salicyaldehydes and these derivatives were evaluated for their anticancer activities in 
various cancer cell lines. The androgen receptor negative prostate (DU145), colorectal 
(DLD-1), non-small cell lung carcinoma (H157), estrogen receptor negative breast 
(BT20) and chronic myeloid leukemia (K562) cell lines were used in this study. This 
study concluded that all the tested compounds have GI50 values less than 100 µM 
against different cancer cell lines and encourage the synthesis of more potent 
sulphonamide coumarin derivatives.  
 
In addition, a library of compounds including the hydroxylated and nitrated derivatives 
of coumarins was evaluated for their cytotoxic activities by using MTT assay against 
human skin melignant melanocytes (SK-MEL-31) and normal human skin fibroblastic 
cells (HS613.SK) in order to verify the selective toxicity of the coumarin derivatives. 
The whole series of the hydroxylated coumarins was found to be more toxic in 
HS613.SK than SK-MEL-31, whereas the novel synthetic nitrated coumarins, 6-nitro,7-
hydroxycoumarin (30) and 3,6,8-trinitro,7-hydroxycoumarin (31) were proven to be 
significantly more toxic to SK-MEL-31 than HS613.SK cells. The results indicated that 
  
 13 
the nitro derivatives of coumarins can be explored as potential chemotherapeutic agents 
(Finn et al., 2001). 
In addition, coumarin and its derivatives are known to be effective in renal cell 
carcinoma (Kokron et al., 1991), prostate cancer (Mohler et al., 1992) and in leukaemia 
treatments (Wang et al., 2002). 
 
1.2.4. Anti-inflammatory and analgesic activities of coumarins 
Several studies have been conducted to explore the anti-inflammatory and analgesic 
properties of coumarins. Maddi and his co-workers (1992) had investigated the 
anti-inflammatory activity of a series of synthetic 3-(benzylideneamino)coumarins and  
found that the 3,4-dichloro analogue (32) inhibited 67% of swelling in rats undergoing 
the carrageenan-induced paw oedema test in three hours. The same compound also 
showed analgesic activity similar to that of aspirin in the acetic acid-induced writhing 
test conducted in mice. 
A novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines was 
synthesized by treating various substituted 3-aryl-1-(3-coumarinyl)propan-1-ones with 
phenylhydrazine in the presence of pyridine. All the synthesized derivatives were 
screened in vivo for their anti-inflammatory and analgesic activities at a dose of 200 
mg/Kg. Among the twelve synthesized compounds, only compounds 33 and 34 showed 
remarkable anti-inflammatory activities in carrageenan-induced paw oedema and in 
adjuvant-induced arthritis in rats. Moreover, these compounds displayed significant 
analgesic and antipyretic activities with minimum ulcerogenic effect (Khode et al., 
2009).  
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A subsequent study also reported the exceptional analgesic and anti-inflammatory 
effects of Schiff bases derived from 7-amino-4-methylcoumarin. In particular, 
compounds 35, 36 and 37 exhibited more potent activities as compared to those of the 
reference drugs (Ronad et al., 2008).  
 
1.2.5. Miscellaneous activities of coumarins 
Anti-coagulant activity of coumarins is well known. Warfarin, a synthetic derivative of 
dicoumarol is a popular anticoagulant drug. Lee et al. (2003) in a bio-assay guided 
isolation of methanol extract of roots of Angelica genuflexa and A. gigas (having a 
potent anti-thrombotic potential), isolated eight pure compounds of coumarin 
derivatives with noteworthy anti-coagulant and anti-platelet activities. Another study 
revealed that the derivatives of 4-methyl-7-hydroxycoumarin can be used as effective 
bio-pesticides against the larvae of Aedes aegypti and Culex quinquefasciatus 
(Deshmukh et al., 2008). Moreover, coumarin and its derivatives are known as 
tyrosinase (Fais et al., 2009), α-glucosidase (Raju et al., 2010) and 5-lipoxygenase 
inhibitors (Grimm et al., 2006). 
Besides the aforementioned biological activities, coumarin derivatives also possess 
spectral, luminescent and lasing properties (Samsonova et al., 2007). Amino coumarins, 
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for instance, are used extensively as active media in dye lasers in the blue-green range 
(Schimitschek et al., 1976, Jones, 1980). In addition, pyrrole bis-coumarins are used as 
fluorescent probes (Shastri et al., 2007).    
 
1.3. Thiazolyl coumarins 
Thaizolyl coumarins are coumarin derivatives, in which one of the coumarin protons 
(usually at C-3) is substituted by a thiazole ring. Amino thiazole group is known as an 
important pharmacophore in medicinal chemistry. Compounds containing thiazole rings 
have remarkable medicinal values due to their potential chemotherapeutic (Liebig et al., 
1974), fungicidal (Pathak et al., 1981), antiviral (Spector et al., 1998) and pesticidal 
(Fan et al., 2006)
 
properties. In addition, 2-aminothiazole derivatives are reported to 
exhibit significant biological activities such as anti-tuberculosis (Sytnik, 2003), 
anti-inflammatory (Holla et al., 2003), enzyme inhibition (Das et al., 2006) and anti-
tumour activities (El-Subbagh et al., 1999). They have also found broad applications in 
the treatment of allergies (Shigenaga et al., 1993), schizophrenia (Ohkubo et al., 1995) 
and hypertension (Patt et al., 1992).  
 
1.3.1. Methods for the synthesis of thiazoles 
Several methods were reported in the literature for introducing the thiazole ring in the 
molecular skeleton. Hantzch synthesis, which was first introduced by a German chemist 
Hantzsch in 1887, is the most valuable and versatile among all thiazole syntheses. This 
method involved the condensation of a compound having two hetero atoms on the same 
carbon with a carbonyl compound bearing one halogen atom on the adjacent carbon 
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(Scheme 1.1). In this reaction, a variety of compounds may serve as nucleophilic 
reagents, such as thiourea, thioamide, thiosemicarbazide, ammonium thiocarbamate or 
dithiocarbamate and their derivatives (Joule et al., 1995). 
 
 
Scheme 1.1: Synthesis of thiazoles by Hantzch reaction 
 
Gabriel’s synthesis (Scheme 1.2) is also used to synthesize arylthiazoles in good yield 
by the treatment of N,N-diformylaminomethyl aryl ketones with phosphorous 
pentasulphide in triethylamine and chloroform (Sheldrake et al., 2006). 
 
 
Scheme 1.2: Synthesis of thiazoles by Gabriel’s synthesis 
A single pot alkylation-cyclization reaction of propargyl bromides with thiourea 
afforded 2-aminothiazoles under microwave irradiation in few minutes as shown in  
(Scheme 1.3) (Castagnolo et al., 2009). 
 
 
Scheme 1.3: Synthesis of thiazoles by alkylation-cyclization reaction  
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Thiazole scaffolds with structural diversity in positions two and five can be synthesized 
by cyclization of α-amido-β-ketoesters by reacting with Lawesson’s reagent ( , -bis(4-
methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-dithione) as explained in Scheme 1.4 
(Sanz-Cervera et al., 2009). 
 
 
Scheme 1.4: Synthesis of thiazoles by cyclization of α-amido-β-ketoesters    
 
Thiazoles can be obtained in good yields by the reaction of 1H-1-( ˊalkynyl -5-methyl-
1,2,3-benzoiodoxathiole,3,3-dioxides with thioamides (Scheme 1.5). The side product 
potassium 2-iodo-5-methylbenzenesulfonate can be recovered easily and is used for the 
regeneration of 1H-1-( ˊalkynyl -5-methyl-1,2,3-benzoiodoxathiole,3,3-dioxides 
quantitatively (Ishiwata and Togo, 2008). 
 
Scheme 1.5: Synthesis of thiazoles by the reaction of 1H-1-( ˊalkynyl -5-methyl-
1,2,3-benzoiodoxathiole,3,3-dioxides with thioamides   
 
In the present study, Hantzsch cyclization was used to introduce thiazole ring into the 
molecular framework. This method has several advantages with wide scope. It allows 
alkyl, aryl or heterocyclic substituents to be place in any position of the 5-membered 
ring. It involves simple work-up and usually the result is a single product.  
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1.3.2. Biological activities of thiazolyl coumarins 
Coumarin derivatives having various substituted thiazole rings at carbon-3 were 
reported to exhibit promising biological activities (Kumar et al., 2008). Siddiqui and 
co-workers (2009) reported the syntheses of some new coumarin-incorporated thiazolyl 
semicarbazones (38) with good anti-convulsant activity, while analgesic and 
anti-inflammatory activities of coumarin thiazolyl quinolones (39) (Kalkhambkar et al., 
2007) are also known.  
 
 
1.3.2.1. Antimicrobial activity of thiazolyl coumarins 
The synthesis of thiazolyl coumarins is attracting great interests of medicinal chemists 
due to their wide range of pharmacological activities, especially remarkable 
antimicrobial activity with broad spectrum. Kamal et al. (2009) synthesized a series of 
coumarin-naphthalimide conjugates (40) linked through the thiazolyl ring by reacting 
aminothiazolyl coumarins with naphthalic anhydride. All the synthesized conjugates 
were assayed against different strains of Gram-positive and Gram-negative bacteria as 
well as few strains of fungi. In addition, anti-cancer activity was also evaluated against 
colon, breast and lung cancer cell lines. Some of the conjugates showed equipotent 
growth inhibition as compared to those of the reference drugs and hence regarded as 
potential  anticancer and antimicrobial agents. 
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In another study, antibacterial and antifungal activities of 2,3-dihydro-2-aryl-4-[4- 
(2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-ylamino]-1,5-benzothiazepines (41) against a 
variety of bacterial strains and some fungal pathogens were investigated (Raval et al., 
2008).  
Furthermore, a group of researchers assayed in vitro antimicrobial activities of 
coumarinyl thiazolopyrimidinones (42) and these compounds were found to be 
specifically active against Gram-positive bacteria but were incapable to inhibit the 
growth of Gram-negative bacterial strains. However, moderate fungal activity against 
Candida albicans and Penicillium chrysogenum was observed but most of the 
compounds were inactive against Aspergillus niger (Yaragatti et al., 2010). 
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A detailed antifungal study of bis-thiazolyl coumarins was conducted by Raghu and 
co-workers (2009). Among all the synthesized compounds, 43 and 44 displayed notable 
activity against most of the tested strains and found to have potent antifungal effect 
against Candida albicans, Aspergillus fumigates, Trichophyton rubrum and 
Trichophyton mentagrophytes. 
In addition, 5-(4-hydroxy-3-methoxyphenyl)-3-[(4-coumarin-3-yl)-thiazole-2-yl)]-2-iso 
xazolines (45) were also reported to exhibit good to excellent activity against 
Gram-negative bacterial strains (Desai et al., 2008).  
Very recently, Chimenti and co-workers (2009, 2010) studied the anti-Helicobacter 
pylori activity of 4-(coumarin-3-yl)thiazol-2-ylhydrazone derivatives against 20 isolates 
of H. pylori. Only three compounds 46, 47 and 48 bearing specific heterocyclic rings 
furan, pyridine and naphthalene respectively on the hydrazone moiety exhibited MIC 
values (8 µg/mL) comparable to that of the reference drug against some clinical strains 
of H. pylori. 
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1.3.2.2. Antituberculosis activity of thiazolyl coumarin 
Some studies have been conducted on the anti-tuberculosis activity of hydrazinyl 
thiazolyl coumarins. Karali and co-workers (2002) synthesized a series of 4-(3-
coumarinyl)-3-cyclohexyl-4-thiazoline-2-onebenzylidenehydrazones (49) via the 
reaction of 3-bromoacetylcoumarins with 1-substitutedbenzylidene-4-cyclohexyl 
thiosemicarbazides. All the synthesized derivatives were screened for anti-tuberculosis 
activity against M. tuberculosis H37Rv and found to inhibit the growth of this strain to 
varying extent. Later, the same group of researchers (Gursoy and Karali, 2003) reported 
the synthesis and anti-tuberculosis activity of 4-(3-coumarinyl)-3-benzyl-4-thiazoline-2-
one benzylidenehydrazones (50). 
Moreover, the synthesis and anti-tubercular activities of acetyl derivatives of 3-(2-
hydroxybenzalhydrazino-4-thiazolyl)coumarins (51) obtained by treating them with 
acetic anhydride in the presence of a catalytic amount of pyridine were also explored 
(Rao and Reddy, 2003). 
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1.4. Research Objectives 
On the basis of all above mentioned evidence, we set out to prepare the new series of 
biologically active agents containing both important pharmacophores, coumarin and 
thiazole rings within the molecular framework. 
The present work focuses on four main research objectives: 
I. To synthesize the new series of heterocyclic compounds by incorporating 
thiazole ring with coumarin nucleus. 
II. To characterise all the synthetic compounds by different spectroscopic 
techniques (IR, 1D & 2D NMR, HRESIMS) and elemental analysis. To 
establish the exact configuration of some derivatives by X-ray crystallography. 
III. To evaluate antimicrobial activities of the synthesized compounds against 
Gram-positive (S. aureus and S. Pyogenes) and Gram-negative (H. influenzae) 
bacteria including Mycobacterium tuberculosis as well as against Candida 
albicans (a fungal strain). 
IV. To evaluate the antioxidant activities of all the synthesized compounds by using 
DPPH radical assay and to compare their antioxidant activities to that of a 
synthetic antioxidant, butylated hydroxytoluene and two natural antioxidants,          
quercetin and catechin. 
 
 
 
 
 
  
 23 
CHAPTER TWO 
EXPERIMENTAL 
 
2.1. Chemicals and Solvents  
The commercial chemicals and reagents used in the syntheses and characterization of all 
the synthesized compounds are as follows: Acetic acid glacial, AR grade (QRëC); 
Acetone, AR grade (QRëC); Acetophenone, 99% (Sigma-Aldrich, USA); Ammonium 
hydroxide, AR grade, 28–30% NH3, (Sigma-Aldrich, USA); Benzophenone, 99% 
(Sigma-Aldrich, USA); Bromine (Merck, Germany); 2-Bromobenzaldehyde, (Acros 
Organics, Belgium); 4-Bromobenzaldehyde, (Acros Organics, Belgium); 5-Bromo,2-
hydroxybenzaldehyde, (Acros Organics, Belgium); 4-Butylbenzaldehyde, (Acros 
Organics, Belgium); Calcium chloride, anhydrous, granular (R & M Chemicals, UK); 2-
Chlorobenzaldehyde, (Acros Organics, Belgium); 4-Chlorobenzaldehyde, (Acros 
Organics, Belgium); Chloroform, AR grade (QRëC); Dichloromethane, AR grade 
(QRëC); Diethyl ether, AR grade (Lab-Scan, Thailand); Dimethyl sulfoxide-d6 for NMR 
(Sigma-Aldrich, USA); 2,4-Dichlorobenzaldehyde, (Acros Organics, Belgium); 
2,4-Dihydroxybenzaldehyde, (Acros Organics, Belgium); Ethanol, 99.7%, denatured, 
AR grade (QRëC); Ethyl acetate, AR grade (Fisher Scientific, UK); Ethyl acetoacetate 
(Sigma-Aldrich, USA); 2-Fluorobenzaldehyde, (Acros Organics, Belgium); 
4-Fluorobenzaldehyde, (Acros Organics, Belgium); 2-Hydroxyacetophenone, (Acros 
Organics, Belgium); 3-Hydroxyacetophenone, (Acros Organics, Belgium); 
4-Hydroxyacetophenone, (Acros Organics, Belgium); 2-Hydroxybenzaldehyde, (Acros 
Organics, Belgium); 3-Hydroxybenzaldehyde, (Acros Organics, Belgium); 
  
 24 
4-Hydroxybenzaldehyde, (Acros Organics, Belgium); 2-Hydroxy,1-naphthaldehyde; 
Methanol, AR grade (QRëC); 2-Methoxybenzaldehyde, (Acros Organics, Belgium); 
4-Methoxybenzaldehyde, (Acros Organics, Belgium); 2-Methylbenzaldehyde, (Acros 
Organics, Belgium); 4-Methylbenzaldehyde, (Acros Organics, Belgium); Molecular 
sieves type 4A, beads (Fluka Switzerland); 1-Naphthaldehyde (Aldrich, USA); 
3-Nitrobenzaldehyde, (Acros Organics, Belgium); Piperidine (BDH, England); Pyridine 
(Aldrich, USA); Potassium bromide, FT-IR grade, (Sigma-Aldrich, USA); 
Salicylaldehyde (Aldrich, USA); TLC silica gel 60 F254, aluminium sheets, 20cm x 
20cm (Merck, Germany); Thiosemicarbazide, 99% (Aldrich, USA); o-Vanillin (Aldrich, 
USA). All chemicals and solvents were of reagent grade. All solvents were used without 
further purification, unless otherwise stated.  
 
2.2. Purification of solvents 
2.2.1. Ethanol free chloroform 
Two methods were used to remove ethanol from chloroform. 
i. First method involved the use of concentrated sulphuric acid for the purification 
of chloroform. Concentrated sulphuric acid was added to the chloroform and the 
solution was swirled gently in a separating funnel. After removing the acid, 
chloroform was washed many times with small portions of distilled water, until 
water after washing had neutral pH. The chloroform was then dried over 
anhydrous calcium chloride for overnight and then distilled. Chloroform purified 
by this method (Williamson et al., 1995) is reported to contain less than 0.001 % 
(w/w) of ethanol. 
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ii.  In the second method, molecular sieves (4Å) were used to obtain ethanol-free 
chloroform. Chloroform was washed four times with distilled water and then 
dried over the molecular sieves (Cohen et al., 2009). 
2.2.2. Dry ethanol 
Ethanol was dried by refluxing it with anhydrous calcium oxide (250 g/L) for 6 hours. 
The mixture was then allowed to stand overnight and then distilled under nitrogen 
(Armarego and Chai, 2009). 
 
2.3.General Experimental Methods  
2.3.1. Reaction Monitoring 
The progress of all reactions was monitored by thin layer chromatography (TLC) at 
regular intervals of 30 minutes. The reaction mixture along with the starting materials 
was spotted on the TLC plates. The TLC plates were developed by using different 
solvent systems such as acetone: n-hexane, chloroform:n-hexane and chloroform: 
methanol. The appearance of product spot and vanishing of reactants spots on the TLC 
plates determined the optimum reaction time for each reaction. The TLC plates were 
visualised either under ultra violet radiation at wavelengths of 254 and 365 nm or by 
developing the spots in an iodine tank. 
 
2.3.2. Moisture-sensitive Reactions 
All moisture sensitive reactions were conducted at normal atmospheric pressure and the 
reaction flasks were affixed with a calcium chloride guard tube. Prior to a reaction, all 
glasswares were pre-dried at 120 
o
C overnight in an oven and assembled hot. Solvents 
